Today: 17 May 2026
Valero stock leaps 9% on Venezuela shock — what investors are watching next
6 January 2026
1 min read

Valero stock leaps 9% on Venezuela shock — what investors are watching next

New York, Jan 5, 2026, 20:13 EST — Market closed

  • Valero Energy shares ended sharply higher as U.S. refiners rallied on Venezuela-driven headlines.
  • Oil settled higher, adding momentum to energy names after a volatile session.
  • Traders are watching Washington’s next steps and Valero’s Jan. 29 earnings for margin clues.

Valero Energy Corp shares were last up 9.2% at $180.57, after trading as high as $184.97, before U.S. markets closed on Monday.

The move tracked a broad bid in oil and refining stocks after President Donald Trump said the United States would take control of Venezuela following the arrest of President Nicolas Maduro. The Trump administration is planning to meet U.S. oil executives later this week, and CBS News reported the talks were expected on Thursday with Energy Secretary Chris Wright, citing an unnamed source.

For refiners, the focus is on Venezuelan crude, typically a “heavy sour” grade — thicker oil with higher sulfur content that needs more complex processing. “This type of crude aligns well with the configuration of U.S. Gulf Coast refineries which were historically designed to process such grades,” Ahmad Assiri, research strategist at Pepperstone, said. Reuters

Oil prices added to the energy tailwind, with Brent settling up $1.01 at $61.76 a barrel and U.S. West Texas Intermediate up $1 at $58.32. Aegis Hedging analysts said the key unknown is how Venezuela’s oil flows change after U.S. actions, with an export embargo still in place.

Valero led gains among major U.S. refiners on the day, outpacing a strong advance across the energy complex that also lifted Chevron and several oilfield services names.

The rally pushed Valero close to the top of its recent range, near a 52-week high around $185.62, leaving traders watching whether the stock can hold above the mid-$170s area where it spent part of the session.

Beyond the geopolitical jolt, investors are turning to fundamentals. Valero operates 15 petroleum refineries with combined throughput capacity of about 3.2 million barrels per day, and it is scheduled to report fourth-quarter and full-year 2025 results on Jan. 29 before the market opens, followed by a 10 a.m. ET conference call.

There are clear risks to the trade. The U.S. embargo remains in effect, and analysts have warned that rebuilding Venezuelan production would require years of work and heavy investment, while policy and legal uncertainty could keep barrels off the market longer than equity buyers are pricing in.

Near-term, traders will parse any readout from Washington’s planned meetings this week for clues on sanctions, waivers and timelines — and watch refining margins through “crack spreads,” the gap between fuel prices and crude oil that acts as a proxy for refinery profitability. The next hard catalyst for Valero is its Jan. 29 earnings report.

Stock Market Today

  • Berkshire Hathaway CEO Greg Abel Revamps Portfolio with Major Stock Changes
    May 16, 2026, 7:29 PM EDT. Berkshire Hathaway, under new CEO Greg Abel, has significantly overhauled its equity portfolio in Q1, highlighted by a 224% increase in Alphabet shares, now Berkshire's seventh largest holding valued at $16.6 billion. Abel added Delta Air Lines and Macy's, while cutting multiple stocks, including a near-total sale of Constellation Brands and complete exit from Amazon shares. The largest reduction by value was in Chevron, cut by 35%, worth over $8 billion. The reshuffle marks a shift away from holdings linked to former portfolio manager Todd Combs, indicating a strategic realignment under Abel's leadership. Alphabet has gained 38% since the quarter ended.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Netflix stock (NFLX) holds steady after hours as CFRA downgrade spotlights Warner deal risk
Previous Story

Netflix stock (NFLX) holds steady after hours as CFRA downgrade spotlights Warner deal risk

Why Commonwealth Bank (ASX:CBA) shares fell 3% as Australia’s CPI test nears
Next Story

Why Commonwealth Bank (ASX:CBA) shares fell 3% as Australia’s CPI test nears

Go toTop